drugset / Trial / NCT06442566

ACTION: Trial of Adding Buprenorphine, CBT, and TMS to Improve Outcomes of Long-Term Opioid Therapy for Chronic Pain

NCT06442566

RandomizedSequentialDouble-blindTreatment

Summary

This study will sequentially evaluate three novel and scalable interventions for at-risk individuals on long term opioid therapy for chronic pain: (1) low-dose transdermal buprenorphine initiation without a period of opioid withdrawal; (2) a brief Cognitive Behavioral Intervention for pain (CBI); and (3) "accelerated" rTMS over the left dorsolateral prefrontal cortex, by examining standardized repeated measures of clinical outcomes at baseline, during treatment, and at 4-, 12-, 24- and 52-week follow-up.

Timeline

Start
2024-08-12
Primary completion
2028-03-31
Completion
2029-03-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Buprenorphine Other / unclassified 5 ug Other
Subject Buprenorphine Other / unclassified 10 ug Other
Subject Buprenorphine Other / unclassified 15 ug Other
Subject Buprenorphine Other / unclassified 20 ug Other